Contingency Management for Hoarding Disorder (HCM)

May 17, 2021 updated by: Hartford Hospital

A Pilot Study of Contingency Management for Hoarding Disorder

Aim 1: To test the efficacy of contingency management for patients with hoarding disorder (HD).

Hypothesis 1. Participants completing CM will show significant pre- to post-treatment decreases in severity of hoarding symptoms and clinician-rated impairment, and significant increases in quality of life.

Exploratory analyses will examine whether effect sizes compare with those of prior trials of cognitive-behavioral therapy (CBT) for HD conducted within our clinic, whether problem severity at follow-up is predicted by hoarding severity measured immediately after treatment completion, and whether readiness for change improves with treatment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The primary aim of the current study is a preliminary investigation of the efficacy of contingency management (CM) in the treatment of hoarding disorder (HD). CM is a highly efficacious treatment that has been used to treat issues such as substance use disorders, medication/ medical regimen nonadherence, and schizophrenia. While the current best-practice treatment for HD (cognitive behavioral therapy; CBT) is efficacious in that it results in significant symptom reduction, many patients continue to have high levels of functional impairment and distressing symptoms after treatment completion. We strongly feel that CM is able to address many of the issues that arise in the context of CBT for hoarding and we feel that the addition of CM to as CBT will result in significant pre- to post-treatment decreases in severity of hoarding symptoms and impairment, and significant increases in quality of life.

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • Hartford, Connecticut, United States, 06106
        • Anxiety Disorders Center, Institute of Lilving

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed with Primary Hoarding Disorder,
  • currently participating in the Hoarding Disorder treatment group at the HH Anxiety Disorders Center

Exclusion Criteria:

  • Not clinically appropriate for a group treatment format (i.e., active suicidality or aggressive behavior, psychosis, current physiological substance dependence, or personality issues that would be expected to substantially interfere with the group milieu; cognitively intact).
  • Participants will also be excluded if they have previously completed CBT for HD.
  • In addition, participants in the CM portion of the treatment will be required to live within one hour travel time of the treatment facility to allow for home visits with the independent rater.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Contingency Management
Receives contingency payments each month based on decluttering scores
Participants in the current study will receive contingencies for improvement in clutter, as measured by a trained, independent in-home rater. Ratings will be completed by after study consent, and once every month thereafter, being conducted at weeks 0, 4, 8, 12, and 16 of treatment. Participants will be reimbursed for each new 1-point reduction in CIR score, a set dollar amount per month for each CIR point reduction they maintain from baseline. Therefore, a perfectly performing patient would earn reimbursement (A CIR reduction of 8 points made in the first month and maintained throughout treatment. If a CIR score is higher than the prior month, the reinforcement schedule will reset to zero.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hoarding Rating Scale (HRS)
Time Frame: Change from week 1 (pre) to week 16 (post)
A brief 5-item interview to rate clutter, difficulty discarding, acquisition, distress, and impairment. Each item is rated on a likert scale from 1 to 8, with higher scores reflective of higher symptom severity.
Change from week 1 (pre) to week 16 (post)
Clutter Image Rating Scale
Time Frame: Change from week 1 (pre) to week 16 (post)
A pictorial measure of clutter severity containing nine photographs depicting increasing levels of clutter. CIR Scores can range from 1 to 9, with picture 1 indicating an absence of clutter and 9 indicative of the highest level of clutter. Each available room will be rated.
Change from week 1 (pre) to week 16 (post)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Readiness Ruler
Time Frame: Change from week 1 (pre) to week 16 (post)
The Readiness Ruler is a brief measure of motivation, which prompts patients with a 10-point likert scale on which they rate readiness, with a score of 0 reflecting "not ready," and a score of 10 reflecting "ready." The Readiness Ruler used in the current study will have patients rate both readiness for treatment and readiness for change.
Change from week 1 (pre) to week 16 (post)
The World Health Organization Quality of Life Scale (WHOQOL-BREF)
Time Frame: Change from week 1 (pre) to week 16 (post)
Was developed by the World Health Organization and field-tested in 18 countries (including the United States) and contains 26 self-report questions, which measure the following broad domains: physical health, psychological health, social relationships, and environment. These four scales can be summed to calculate a total quality of life (QOL) score, ranging from 0 (least favorable health status)to 100 (most favorable health status).
Change from week 1 (pre) to week 16 (post)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Blaise l Worden, Ph.D., Hartford Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

November 12, 2013

First Submitted That Met QC Criteria

May 17, 2021

First Posted (Actual)

May 20, 2021

Study Record Updates

Last Update Posted (Actual)

May 20, 2021

Last Update Submitted That Met QC Criteria

May 17, 2021

Last Verified

May 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hoarding Disorder

Clinical Trials on Contingency Management

Subscribe